 |
|
|
| |
Sustained Virological Response After Protease Inhibitor-based Therapy For Hepatitis C Recurrence After Liver Transplantation: A Multicentric European Experience
|
| |
| |
Reported by Jules Levin
AASLD 2013 Nov 1-5 Wash DC
AASLD: Pretransplant Sofosbuvir and Ribavirin to Prevent Recurrence of HCV Infection After Liver Transplantation - (11/06/13)
AASLD: Sofosbuvir and Ribavirin for the Treatment of Established Recurrent Hepatitis C Infection After Liver Transplantation: Preliminary Results of a Prospective, Multicenter Study - (11/05/13)
AASLD: Initial Evaluation of the Sofosbuvir Compassionate Use Program for Patients With Severe Recurrent HCV Following Liver Transplantation - (11/06/13)
A Coilly, J Dumortier, D Botta-Fridlund, M Latournerie, V Leroy, GP. Pageaux, E Giostra, C Moreno, B Roche, TM Antonini, H Agostini, P Lebray, S Radenne, AC Saouli, Y Calmus, L Alric, M Debette-Gratien, V De Ledinghen, F Durand, C Duvoux, D Samuel, JC Duclos-Vallee
|
| |
|
|
|
|
|
